Candel Therapeutics Inc (CADL)
8.575
+0.78
(+9.94%)
USD |
NASDAQ |
May 28, 16:00
8.86
+0.28
(+3.32%)
After-Hours: 06:13
Candel Therapeutics Free Cash Flow: -32.19M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -32.19M |
| December 31, 2023 | -34.70M |
| September 30, 2023 | -34.39M |
| June 30, 2023 | -35.08M |
| March 31, 2023 | -35.45M |
| December 31, 2022 | -32.72M |
| September 30, 2022 | -31.30M |
| Date | Value |
|---|---|
| June 30, 2022 | -28.98M |
| March 31, 2022 | -26.42M |
| December 31, 2021 | -24.05M |
| September 30, 2021 | -22.18M |
| June 30, 2021 | -17.12M |
| March 31, 2021 | -14.19M |
| December 31, 2020 | -9.071M |
Free Cash Flow Range, Past 5 Years
-35.45M
Minimum
Mar 2023
-9.071M
Maximum
Dec 2020
-26.99M
Average
-30.14M
Median
Free Cash Flow Benchmarks
| Allurion Technologies Inc | -63.73M |
| AngioDynamics Inc | -23.46M |
| Eliem Therapeutics Inc | -7.241M |
| Macrogenics Inc | -113.88M |
| GlycoMimetics Inc | -33.81M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.438M |
| Cash from Investing (Quarterly) | -0.007M |
| Cash from Financing (Quarterly) | -1.255M |
| Free Cash Flow Per Share (Quarterly) | -0.2892 |
| Free Cash Flow Yield | -12.94% |